ZSCAN9

Across TCGA pan-cancer cohorts, ZSCAN9 mass-spec protein is linked to patient survival in 1 of 34 cancer types, making it a survival-associated ZSCAN9 data layer compared with 30 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in glioblastoma multiforme (GBM), where higher ZSCAN9 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated ZSCAN9 expression acts as an unfavorable survival marker.

GBM are the cancer types where ZSCAN9 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
GBM	OS	Tertile	All	0.340	0.977	.024	6	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

ZSCAN9–GBM (OS)

Open the GBM breakdown →